Nuveen Asset Management, LLC Tg Therapeutics, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,798,989 shares of TGTX stock, worth $64.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,798,989
Previous 2,031,324
11.44%
Holding current value
$64.3 Million
Previous $47.5 Million
13.97%
% of portfolio
0.02%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding TGTX
# of Institutions
406Shares Held
92.4MCall Options Held
2.28MPut Options Held
1.78M-
Vanguard Group Inc Valley Forge, PA15.8MShares$565 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$407 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$272 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$125 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$109 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.19B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...